The DOI matches its Crossref record.
A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic Neuropathy
Abstract
A double-blind, randomized, placebo-controlled crossover trial of the aldose reductase inhibitor sorbinil was undertaken in 15 patients (age 35–68 yr) with chronic painful diabetic neuropathy. Treatment was evaluated by subjective pain responses, clinical examination, vibration perception threshold, motor and sensory nerve electrophysiology, and cardiovascular reflex tests of autonomie nerve function. Among the many measurements, only pain, tendon reflex scores, and sural sensory potential amplitude improved significantly during sorbinil administration, while scores of clinical sensory examination deteriorated. Four patients experienced an idiosyncratic reaction that rapidly recovered on discontinuing the drug. This study suggests that aldose reductase inhibitor treatment with sorbinil may have an effect on symptomatic diabetic neuropathy in man.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Flier, J. S., Underhill, L. H., Greene, D. A., Lattimer, S. A., & Sima, A. A. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703053161007 · Cited by 897
Ziegler, D., Hanefeld, M., Ruhnau, K. J., Mei\ner, H. P., Lobisch, M., Sch�tte, K., Gries, F. A., & The ALADIN Study Group (1995) · Diabetologia · doi:10.1007/bf00400603 · Cited by 525
Diabetic peripheral neuropathy: Current perspective and future directions
Singh, R., Kishore, L., & Kaur, N. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.12.005 · Cited by 400
The role of aldose reductase in the development of diabetic complications
Kador, P. F. (1988) · Medicinal Research Reviews · doi:10.1002/med.2610080302 · Cited by 297
Sima, A. A. F., Bril, V., Nathaniel, V., McEwen, T. A., Brown, M. B., Lattimer, S. A., & Greene, D. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190905 · Cited by 293
Metadata
- Authors
- Young, R. J., Ewing, D. J., & Clarke, B. F.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1983-10-01
- Volume
- 32
- Issue
- 10
- Pages
- 938-942
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2151772902
- Cited by
- 188
- References
- 0
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic Neuropathy. https://app.cochat.ai/papers/10.2337/diab.32.10.938
- The paper
- Young, R. J., Ewing, D. J., & Clarke, B. F. (1983). A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic Neuropathy. Diabetes. https://doi.org/10.2337/diab.32.10.938
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.